Skip to main navigation
Omnicell
Skip to navigation
  • Home
  • About Omnicell
  • Investor Relations
  • Financials & Filings

Financials & Filings

Here you will find a summary of Omnicell, Inc.'s latest financial information.

Show all

2020

Fourth Quarter
  • Omnicell Reports Fiscal Year and Fourth Quarter 2020 Results
  • Omnicell Fourth Quarter 2020 Earnings Call
  • Complementary Summary of Q4 2020 Financial Results 214.2 KB
  • Form 10-K

Proxy Statements

Filing date View
Apr 7, 2020 View HTML
0001047469-20-002156.pdf
0001047469-20-002156.xls
Apr 1, 2019 View HTML
0001047469-19-001833.pdf
0001047469-19-001833.xls

Form 10-K

Filing date View
Feb 24, 2021 View HTML
0000926326-21-000007.pdf
0000926326-21-000007.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 26, 2020 View HTML
0000926326-20-000010.pdf
0000926326-20-000010.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Form 10-Q

Filing date View
Oct 30, 2020 View HTML
0000926326-20-000034.pdf
0000926326-20-000034.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 31, 2020 View HTML
0000926326-20-000023.pdf
0000926326-20-000023.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Share Related Items

Market Capitalization (Mil) $5,353.08
Shares Outstanding (Mil) 43.04
Shares Outstanding, Average (FY) (Mil) 43.74
Float (Mil) 41.68

Data provided by Kaleidoscope.

INVESTOR PRESENTATIONS
Investor Presentation - February 2021 2.9 MB
J.P. Morgan 39th Annual Healthcare Conference Presentation – January 2021 1.5 MB
Omnicell to Acquire PSG’s 340B Link Business 501.4 KB

Shareholder Tools

Printed Materials
Email Alerts
Download Library
RSS News Feeds
Print
:

Day Range:

52-week Range:

Volume:

on

Site 'Sub' Navigation:

Section Navigation:

About Omnicell

Investor Relations

  • Investor Relations
  • Stock Information
    • Analyst Coverage
    • Historic Stock Lookup
    • Key Ratios
    • Investment Calculator
  • Financials & Filings
    • Annual Reports and Proxies
    • Quarterly Results
    • SEC Filings
  • Corporate Governance
  • Press Releases
  • Events & Presentations
  • Investor Contact
  • Intra
  • 3 mo.
  • 6 mo.
  • 1 yr.